Use of pegylated G-SCF compared to G-SCF to mobilize patients with newly diagnosed myeloma undergoing ASCT: why is a single injection unable to overcome years of practice with G-CSF?

V. Robin; L. Garderet; A Triffet; M Lambermont; A. Deweweire; C. Doyen; Ivan Van Riet; D. Mayne; Yasmina Bouko

Use of pegylated G-SCF compared to G-SCF to mobilize patients with newly diagnosed myeloma undergoing ASCT: why is a single injection unable to overcome years of practice with G-CSF?

V. Robin, L. Garderet, A Triffet, M Lambermont, A. Deweweire, C. Doyen, Ivan Van Riet, D. Mayne, Yasmina Bouko

Research output: Contribution to journal › Meeting abstract (Journal)

53 Citations (Scopus)

Original language	English
Pages (from-to)	210-210
Journal	Bone Marrow Transplantation
Volume	48
Issue number	s2
Publication status	Published - Apr 2013
Event	39th Annual Meeting of the European Group for Blood and Marrow Transplantation - London, United Kingdom Duration: 7 Apr 2013 → 10 Apr 2013

Keywords

myeloma

Cite this

@article{4cb149307d494d25bfe1bea32be648c8,

title = "Use of pegylated G-SCF compared to G-SCF to mobilize patients with newly diagnosed myeloma undergoing ASCT: why is a single injection unable to overcome years of practice with G-CSF?",

keywords = "myeloma",

author = "V. Robin and L. Garderet and A Triffet and M Lambermont and A. Deweweire and C. Doyen and {Van Riet}, Ivan and D. Mayne and Yasmina Bouko",

year = "2013",

month = apr,

language = "English",

volume = "48",

pages = "210--210",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Nature Publishing Group",

number = "s2",

note = "39th Annual Meeting of the European Group for Blood and Marrow Transplantation ; Conference date: 07-04-2013 Through 10-04-2013",